Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Terlipin powder for injection

Dexa Medica

Ingredients in every vial

Terlipressin 1 mg

Each package contains

1 vial of 1 mg

Dosage form

Powder for injection

Dosage formPowder for Injection

Flavour

None

W.H.O. classification

H01C
H01C

A.T.C. Level 1

Anatomical Main group

H - Systemic hormonal preparations; excluding sex hormones and insulins
H01C

A.T.C. Level 2

Therapeutic subgroup

H01 - Pituitary and Hypothalamic Hormones and Analogues
H01C

A.T.C. Level 3

Pharmacological subgroup

H01C - Hypothalamic Hormones

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.

Indication

Bleeding esophageal varices
Terlipressin is indicated for the treatment of bleeding esophageal varices.

Dosage

18 TO 65 YEARS OLD
Initially, an intravenous (IV) injection of 2 mg terlipressin is given every 4 hours. The treatment should be maintained until bleeding has been controlled for 24 hours, but up to a maximum of 48 hours. After the initial dose, the dose can be adjusted to 1 mg IV every 4 hours in patients with body weight <50 kg or if adverse effects occur.

0 TO 18 YEARS OLD
No data are available regarding dosage recommendation in these patient populations.

65 YEARS OLD AND ABOVE
No data are available regarding dosage recommendation in these patient populations.